![Steven Hoerter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Hoerter
Président chez
MBX BIOSCIENCES, INC.
Fortune : 1 M $ au 31/05/2026
Profil
Mr. Steven L.
Hoerter is an Executive Chairman at MBX Biosciences, Inc., an Independent Director at C4 Therapeutics, Inc. and an Independent Director at Oric Pharmaceuticals, Inc. He is on the Board of Directors at C4 Therapeutics, Inc., Oric Pharmaceuticals, Inc. and Yarrow Bioscience, Inc. /New/.
Mr. Hoerter was previously employed as an Independent Director by Constellation Pharmaceuticals, Inc., a President & Chief Executive Officer by Deciphera Pharmaceuticals, Inc., an Independent Director by Ignyta, Inc., a Chief Commercial Officer by Agios Pharmaceuticals, Inc., an Independent Director by Constellation Pharmaceuticals, Inc., a Chief Commercial Officer & Executive VP by Clovis Oncology, Inc., a Director-Pipeline Development by Genentech, Inc., a President & Chief Executive Officer by Deciphera Pharmaceuticals LLC, and a GM, Head-Sub-Saharan Africa & Indian Ocean Region by Roche Group.
He received his undergraduate degree from Bucknell University, a graduate degree from Krannert School of Management and an MBA from the University of Tilburg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MBX BIOSCIENCES, INC. 0,07 % | 04/06/2026 | 31 938 ( 0,07 % ) | 1 M $ | 31/05/2026 |
| 24/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Steven Hoerter
| Sociétés | Poste | Début |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 13/08/2021 |
| C4 THERAPEUTICS, INC. | Directeur/Membre du Conseil | 19/11/2024 |
| MBX BIOSCIENCES, INC. | Président | 06/11/2025 |
Anciens postes connus de Steven Hoerter
| Sociétés | Poste | Fin |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Directeur Général | 01/10/2024 |
| CONSTELLATION PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 15/07/2021 |
| AGIOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2019 |
| IGNYTA INC | Directeur/Membre du Conseil | 07/02/2018 |
| CONSTELLATION PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/02/2018 |
Formation de Steven Hoerter
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
50
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Roche Group
 Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
University of Tilburg
 University of Tilburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bucknell University
 Bucknell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs targeting regulators of epigenetic function | Health Technology |
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Discovers and develops pharmaceutical preparations | Health Technology |
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
Krannert School of Management
 Krannert School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oric Pharmaceuticals, Inc.
 Oric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceutical products | Health Technology |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Deciphera Pharmaceuticals, Inc.
 Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drug candidates to improve the lives of cancer patients | Health Technology |
MBX Biosciences, Inc.
 MBX Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel precision peptide therapies for endocrine & metabolic disorders | Health Technology |
